Lipotox Liquid
NDC Package 43857-0636-1
Package Information
Lipotox (squalene, cholesterinum, estradiol, progesterone, aspartame, benzalkonium chloride, formalinum, methylene chloride, methylparaben, propylparaben, sodium benzoate, sodium citrate, titanium dioxide, zincum oxydatum, arsenicum album, lycopodium clavatum, nux vomica, phosphoricum acidum, phosphorus, aceticum acidum, benzoicum acidum, benzyl alcohol, boricum acidum, chlorinum, cortisone aceticum, eugenol, folliculinum, isopropyl palmitate, lacticum acidum, petroleum jelly, phenyl butazone, plumbum metallicum,) liquids is 10 drops orally, 3 times a day. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0636.
Identification & Billing
Clinical Specifications
- ACETIC ACID 30 [hp_X]/mL
- ANHYDROUS TRISODIUM CITRATE 30 [hp_X]/mL
- ARSENIC TRIOXIDE 30 [hp_X]/mL
- ASPARTAME 30 [hp_X]/mL
- BENZALKONIUM CHLORIDE 30 [hp_X]/mL
- BENZOIC ACID 30 [hp_X]/mL
- BENZYL ALCOHOL 30 [hp_X]/mL
- BORIC ACID 30 [hp_X]/mL
- CHLORINE 30 [hp_X]/mL
- CHOLESTEROL 12 [hp_X]/mL
- CORTICOTROPIN 30 [hp_C]/mL
- CORTISONE ACETATE 30 [hp_X]/mL
- ESTRADIOL 12 [hp_X]/mL
- ESTRONE 30 [hp_X]/mL
- EUGENOL 30 [hp_X]/mL
- FORMALDEHYDE SOLUTION 30 [hp_X]/mL
- ISOPROPYL PALMITATE 30 [hp_X]/mL
- LACTIC ACID, DL- 30 [hp_X]/mL
- LEAD 30 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 30 [hp_X]/mL
- METHYLENE CHLORIDE 30 [hp_X]/mL
- METHYLPARABEN 30 [hp_X]/mL
- PETROLATUM 30 [hp_X]/mL
- PHENYLBUTAZONE 30 [hp_X]/mL
- PHOSPHORIC ACID 30 [hp_X]/mL
- PHOSPHORUS 30 [hp_X]/mL
- POTASSIUM SORBATE 30 [hp_X]/mL
- PROGESTERONE 12 [hp_X]/mL
- PROPYLPARABEN 30 [hp_X]/mL
- RESORCINOL 30 [hp_X]/mL
- SALICYLIC ACID 30 [hp_X]/mL
- SODIUM BENZOATE 30 [hp_X]/mL
- SORBITOL 30 [hp_X]/mL
- SQUALENE 8 [hp_X]/mL
- STEARYL ALCOHOL 30 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 30 [hp_X]/mL
- TITANIUM DIOXIDE 30 [hp_X]/mL
- XYLITOL 30 [hp_X]/mL
- ZINC OXIDE 30 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Adrenocorticotropic Hormone - [CS]
- Adrenocorticotropic Hormone - [EPC] (Established Pharmacologic Class)
- Allergens - [CS]
- Ammonium Ion Binding Activity - [MoA] (Mechanism of Action)
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Estradiol Congeners - [CS]
- Estrogen Receptor Agonists - [MoA] (Mechanism of Action)
- Estrogen - [EPC] (Established Pharmacologic Class)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Nitrogen Binding Agent - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Pediculicide - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Progesterone - [CS]
- Progesterone - [EPC] (Established Pharmacologic Class)
- Seed Storage Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0636 - Lipotox
- 43857-0636-1 - 30 mL in 1 BOTTLE, DISPENSING
- 43857-0636 - Lipotox
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0636-1 identifies a specific commercial package of 30 ml in 1 bottle, dispensing of Lipotox, a human over the counter drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains acetic acid; anhydrous trisodium citrate; arsenic trioxide; aspartame; benzalkonium chloride; benzoic acid; benzyl alcohol; boric acid; chlorine; cholesterol; corticotropin; cortisone acetate; estradiol; estrone; eugenol; formaldehyde solution; isopropyl palmitate; lactic acid, dl-; lead; lycopodium clavatum spore; methylene chloride; methylparaben; petrolatum; phenylbutazone; phosphoric acid; phosphorus; potassium sorbate; progesterone; propylparaben; resorcinol; salicylic acid; sodium benzoate; sorbitol; squalene; stearyl alcohol; strychnos nux-vomica seed; titanium dioxide; xylitol; zinc oxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on September 05, 2023. The current certification is valid through December 31, 2026.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857063601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.